Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

NCT06789705 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Central Diabetes Insipidus

Interventions

DRUG: MDMA
OTHER: Placebo

Sponsor

University Hospital, Basel, Switzerland